Abstract
Background Plasmodium falciparum malaria remains a major cause of illness and death in sub-Saharan Africa. Young children bear the brunt of the disease and though older children and adults suffer relatively fewer clinical attacks, they remain susceptible to asymptomatic P. falciparum infection. A better understanding of the host factors associated with immunity to clinical malaria and the ability to sustain asymptomatic P. falciparum infection will aid the development of improved strategies for disease prevention.Methods and FindingsHere we investigate whether full differential blood counts can predict susceptibility to clinical malaria among Kenyan children sampled at five annual cross-sectional surveys. We find that the ratio of monocytes to lymphocytes, measured in peripheral blood at the time of survey, directly correlates with risk of clinical malaria during follow-up. This association is evident among children with asymptomatic P. falciparum infection at the time the cell counts are measured (Hazard ratio (HR) = 2.7 (95% CI 1.42, 5.01, P = 0.002) but not in those without detectable parasitaemia (HR = 1.0 (95% CI 0.74, 1.42, P = 0.9).ConclusionsWe propose that the monocyte to lymphocyte ratio, which is easily derived from routine full differential blood counts, reflects an individual's capacity to mount an effective immune response to P. falciparum infection.
Highlights
Plasmodium falciparum malaria is still a major cause of morbidity and mortality in sub-Saharan Africa where the greatest burden of disease is borne by young children [1,2]
We propose that the monocyte to lymphocyte ratio, which is derived from routine full differential blood counts, reflects an individual’s capacity to mount an effective immune response to P. falciparum infection
We find that among children with asymptomatic P. falciparum infection at the time their full differential blood counts are measured, high ML ratio is associated with an increased risk of clinical malaria episodes during follow-up
Summary
Plasmodium falciparum malaria is still a major cause of morbidity and mortality in sub-Saharan Africa where the greatest burden of disease is borne by young children [1,2]. Substantial clinical immunity develops following repeated natural exposure to P. falciparum such that clinical malaria tends to be less frequent in children over 5 years of age and adults. Older children and adults remain susceptible to asymptomatic, often chronic, P. falciparum infections to which immunity probably never occurs [3,4]. The specific host factors underlying susceptibility to clinical malaria despite the ability to sustain asymptomatic P. falciparum infection are poorly understood. A better understanding of the host factors associated with immunity to clinical malaria and the ability to sustain asymptomatic P. falciparum infection will aid the development of improved strategies for disease prevention
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have